Royal Bank of Canada
TTHI

Royal Bank of Canada’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Royal Bank of Canada’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,664
Closed -$12K – 6906
2016
Q2 		$12K Buy
7,664
+7,024
+1,098% +$6.09K ﹤0.01% 5707
2016
Q1 		$1K Sell
640
-6,400
-91% -$7.4K ﹤0.01% 6300
2015
Q4 		$14K Buy
7,040
+6,400
+1,000% +$12.2K ﹤0.01% 5870
2015
Q3 		$1K Hold
640
– – ﹤0.01% 6598
2015
Q2 		$2K Hold
640
– – ﹤0.01% 6415
2015
Q1 		$5K Buy
640
+18
+3% +$124 ﹤0.01% 5776
2014
Q4 		$5K Hold
622
– – ﹤0.01% 5834
2014
Q3 		$5K Hold
622
– – ﹤0.01% 5670
2014
Q2 		$4K Hold
622
– – ﹤0.01% 5647
2014
Q1 		$5K Hold
622
– – ﹤0.01% 5601
2013
Q4 		$3K Hold
622
– – ﹤0.01% 5750
2013
Q3 		$3K Hold
622
– – ﹤0.01% 5837
2013
Q2 		$2K Buy
+622
New +$1.76K ﹤0.01% 5679

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Royal Bank of Canada's TTHI Position: Q3 2016 in Review

Royal Bank of Canada sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 7,664 shares — an estimated $12K sold.

Royal Bank of Canada first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $14K in Q4 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Royal Bank of Canada reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 7,664 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $12K.
  • Royal Bank of Canada first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • Royal Bank of Canada's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $14K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Royal Bank of Canada's 13F filing for Q3 2016, filed 14 Nov 2016.